Evidence map›Paper›PMID 42496916›Full record

ReviewAbdominal radiology (New York)2026

Not always a perfect match: discrepancies between PSMA PET/CT and MRI in prostate cancer diagnosis and staging.

Ana Lemos, Sungmin Woo, Ana Novaes, Maria Lucano, Jadson Oliveira, Cecilia Torres, Olivia Fukumori, Gabriel Gouvea, Rodolfo Reis, Alberto Vargas and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ana LemosDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil. anareislemos@gmail.com.
Sungmin WooDepartment of Radiology, New York University Langone Medical Center, New York, USA.
Ana NovaesDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Maria LucanoDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Jadson OliveiraDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Cecilia TorresDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Olivia FukumoriDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Gabriel GouveaDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Rodolfo ReisDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.
Alberto VargasDepartment of Radiology, New York University Langone Medical Center, New York, USA.
Valdair MugliaDepartment of Medical Images, Oncology and Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) and prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) are increasingly used together in patients with suspected or confirmed prostate cancer (PCa). Discordant findings are common because these modalities evaluate different biological and anatomical aspects of the disease. MRI is best suited for intraprostatic lesion detection and local staging, whereas PSMA PET/CT is superior for assessing nodal and distant metastases and may also contribute to selected diagnostic pathways. This review explains the reasons for these discrepancies, discusses their clinical implications, and provides practical guidance for interpreting and managing discordant findings.

Indexed as

GA-68 PSMA-11Magnetic resonance imagingPositron emission tomographyProstate cancer

Identifiers

PMID42496916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.